Weller, M., Wick, W., Hegi, M. E., Stupp, R., & Tabatabai, G. (2010). Should biomarkers be used to design personalized medicine for the treatment of glioblastoma? Future oncology, 6(9), . https://doi.org/10.2217/fon.10.113
Chicago Style (17th ed.) CitationWeller, Michael, Wolfgang Wick, Monika E. Hegi, Roger Stupp, and Ghazaleh Tabatabai. "Should Biomarkers Be Used to Design Personalized Medicine for the Treatment of Glioblastoma?" Future Oncology 6, no. 9 (2010). https://doi.org/10.2217/fon.10.113.
MLA (9th ed.) CitationWeller, Michael, et al. "Should Biomarkers Be Used to Design Personalized Medicine for the Treatment of Glioblastoma?" Future Oncology, vol. 6, no. 9, 2010, https://doi.org/10.2217/fon.10.113.
Warning: These citations may not always be 100% accurate.